Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies

Article Type
Changed
Thu, 11/15/2018 - 08:38
Display Headline
Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies
Article PDF
Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 70(7)
Publications
Topics
Page Number
624-626, 628-631
Sections
Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Gustavo A. Cardenas, MD
Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic

José M. Cabral, MD
Department of Endocrinology, Cleveland Clinic Florida

Camilo A. Leslie, MD, MBA
Department of Endocrinology, Cleveland Clinic Florida; Associate Professor of Medicine (affiliate), University of South Florida College of Medicine

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 2950 Cleveland Clinic Florida Boulevard, Weston, FL 33331; email: lesliec2@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(7)
Issue
Cleveland Clinic Journal of Medicine - 70(7)
Page Number
624-626, 628-631
Page Number
624-626, 628-631
Publications
Publications
Topics
Article Type
Display Headline
Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies
Display Headline
Amiodarone induced thyrotoxicosis: Diagnostic and therapeutic strategies
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

New insulin replacement technologies: Overcoming barriers to tight glycemic control

Article Type
Changed
Mon, 03/11/2019 - 08:43
Display Headline
New insulin replacement technologies: Overcoming barriers to tight glycemic control
Article PDF
Author and Disclosure Information

Camilo A. Leslie, MD
Department of Endocrinology, Cleveland Clinic Florida

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Ft. Lauderdale, FL 33309

Issue
Cleveland Clinic Journal of Medicine - 66(5)
Publications
Page Number
293-302
Sections
Author and Disclosure Information

Camilo A. Leslie, MD
Department of Endocrinology, Cleveland Clinic Florida

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Ft. Lauderdale, FL 33309

Author and Disclosure Information

Camilo A. Leslie, MD
Department of Endocrinology, Cleveland Clinic Florida

Address: Camilo A. Leslie, MD, Department of Endocrinology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Ft. Lauderdale, FL 33309

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 66(5)
Issue
Cleveland Clinic Journal of Medicine - 66(5)
Page Number
293-302
Page Number
293-302
Publications
Publications
Article Type
Display Headline
New insulin replacement technologies: Overcoming barriers to tight glycemic control
Display Headline
New insulin replacement technologies: Overcoming barriers to tight glycemic control
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media